STOCK TITAN

Cue Biopharma: Balyasny reports about 5.88% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Cue Biopharma, Inc. (CUE) ownership disclosure identifies Balyasny Asset Management L.P., BAM GP LLC, Balyasny Asset Management Holdings LP, Dames GP LLC and Dmitry Balyasny as persons who may each be deemed to beneficially own the same 427,231-share block, approximately 5.88% of the class. Each reports sole voting and dispositive power over the block. Cue Biopharma had 7,264,414 shares outstanding as of August 12, 2026.

Beneficial ownership 427,231 shares Each of the five reporting persons may be deemed to beneficially own the same block.
Percent of class Approximately 5.88% Reported for each reporting person.
Shares outstanding 7,264,414 shares Cue Biopharma shares outstanding as of August 12, 2026.
beneficially owned technical
"Aggregate Amount Beneficially Owned by Each Reporting Person"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
sole voting power technical
"Sole Voting Power 427,231.00"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
sole dispositive power technical
"Sole Dispositive Power 427,231.00"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
investment manager technical
"BAM, the investment manager of Atlas Diversified Master Fund, Ltd."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CUE shares do the Balyasny reporting persons beneficially own?

Each of the five reporting persons may be deemed to beneficially own the same 427,231 shares, approximately 5.88% of the class. Each reports sole voting and dispositive power over that block.

Who receives dividends from the CUE shares reported by Balyasny?

Atlas Diversified Master Fund, Ltd. has the right to receive dividends and proceeds from sales of the reported securities. It is identified as the direct holder of the shares and as an investment management client of Balyasny Asset Management L.P.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





22978P205

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



BALYASNY ASSET MANAGEMENT L.P.
Signature:/s/ Scott Schroeder
Name/Title:Scott Schroeder / Authorized Signatory
Date:11/16/2026
BAM GP LLC
Signature:/s/ Scott Schroeder
Name/Title:Scott Schroeder / Authorized Signatory
Date:11/16/2026
Balyasny Asset Management Holdings LP
Signature:/s/ Scott Schroeder
Name/Title:Scott Schroeder / Authorized Signatory
Date:11/16/2026
Dames GP LLC
Signature:/s/ Scott Schroeder
Name/Title:Scott Schroeder / Authorized Signatory
Date:11/16/2026
Dmitry Balyasny
Signature:/s/ Dmitry Balyasny
Name/Title:Dmitry Balyasny / Self
Date:11/16/2026

Keep reading